Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $45,850 | 42 | 63.4% |
| Unspecified | $26,449 | 21 | 36.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $45,850 | 42 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $17,366 | 17 | $0 (2020) |
| Novartis Pharma AG | $9,083 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,050 | 6 | Amgen Inc. ($8,050) |
| 2023 | $8,050 | 7 | Amgen Inc. ($8,050) |
| 2022 | $7,000 | 6 | Amgen Inc. ($7,000) |
| 2021 | $10,562 | 7 | Amgen Inc. ($7,700) |
| 2020 | $15,601 | 12 | Amgen Inc. ($6,300) |
| 2019 | $8,750 | 10 | Amgen Inc. ($4,900) |
| 2018 | $14,286 | 15 | Regeneron Pharmaceuticals, Inc. ($10,436) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 12/03/2024 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Cardiology | ||||||
| 06/11/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 05/28/2024 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Neuroscience | ||||||
| 03/25/2024 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Cardiology | ||||||
| 12/19/2023 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Neuroscience | ||||||
| 11/08/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 09/27/2023 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiology | ||||||
| 06/19/2023 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Neuroscience | ||||||
| 06/05/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 03/23/2023 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiology | ||||||
| 03/15/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 12/15/2022 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Neuroscience | ||||||
| 10/07/2022 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiology | ||||||
| 08/26/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 06/13/2022 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Neuroscience | ||||||
| 03/30/2022 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Cardiology | ||||||
| 02/09/2022 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Neuroscience | ||||||
| 11/04/2021 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Neuroscience | ||||||
| 09/27/2021 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiology | ||||||
| 07/27/2021 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Neuroscience | ||||||
| 05/26/2021 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Neuroscience | ||||||
| 05/06/2021 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Cardiology | ||||||
| 04/07/2021 | Novartis Pharma AG | AIMOVIG (Biological) | — | Cash or cash equivalent | $2,862.00 | Research |
| Study: CAMG334A2304 • Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF REGN475 IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP | Regeneron Pharmaceuticals, Inc. | $17,366 | 17 |
| CAMG334A2304 | Novartis Pharma AG | $9,083 | 4 |
About Barry Davis
Barry Davis is a Public Health & General Preventive Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2018. The National Provider Identifier (NPI) number assigned to this provider is 1578047635.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Barry Davis has received a total of $72,299 in payments from pharmaceutical and medical device companies, with $8,050 received in 2024. These payments were reported across 63 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($45,850).
Practice Information
- Specialty Public Health & General Preventive Medicine
- Location Houston, TX
- Active Since 09/24/2018
- Last Updated 07/31/2023
- Taxonomy Code 2083P0901X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578047635
Products in Payments
- Repatha (Biological) $23,450
- Aimovig (Biological) $15,750
- AMG334A_AIMOVIG_NEUROSCIENCE (Biological) $6,221
- AIMOVIG (Biological) $2,862
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Public Health & General Preventive Medicine Doctors in Houston
Dr. Orin Hall, M.d, M.D
Public Health & General Preventive Medicine — Payments: $462.75
Dr. Steven Harris, M. D., M. Sc, M. D., M. SC
Public Health & General Preventive Medicine — Payments: $16.18
J. Xavier Castillo, Md, MD
Public Health & General Preventive Medicine
Elizabeth Frenzel, M.d, M.D
Public Health & General Preventive Medicine
Margaret Spitz, M.d., Mph, M.D., MPH
Public Health & General Preventive Medicine
Margaret Gale Rowe, Md, MD
Public Health & General Preventive Medicine